Summary
Isolated segments of the guinea-pig small intestine were vascularly perfused and the release of 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) into the portal venous effluent determined by high pressure liquid chromatography with electrochemical detection. Release of acetylcholine from isolated superfused intestinal segments was determined as outflow of [3H]radioactivity from preparations preincubated with [3H]choline. Cisplatin (3 μM) increased the outflow of 5-HT and 5-HIAA by about 90%. At 30 and 100 μM cisplatin decreased the outflow of 5-HT and its metabolite by 40%–50%. The stimulatory effect of cisplatin was consistently observed only when the bicarbonate-phosphate buffer of the Tyrode's solution was replaced by HEPES-buffer. The stimulatory effect of cisplatin was abolished in the absence of extracellular calcium or presence of tetrodotoxin (1 μM). The stimulatory effect of cisplatin was also prevented by hexamethonium (100 μM) or scopolamine (100 nM). The 5-HT3 receptor antagonists ondansetron and ICS 205-930 in concentrations as low as 1 pM also abolished the stimulatory effect of cisplatin. The 5-HT3 receptor antagonist MDL 72222 prevented the stimulatory effect of cisplatin only at a concentration of 1 μM. None of the 5-HT3 receptor antagonists alone significantly altered the outflow of 5-HT and 5-HIAA.
Cisplatin (3 μM) enhanced the outflow of [3H]radioactivity from intestinal segments and caused longitudinal muscle contractions that were abolished by 100 nM scopolamine.
In conclusion, cisplatin, at concentrations which occur during anti-cancer therapy in humans and induce emesis, increases the release of 5-HT from the enterochromaffin cells of the small intestine of the guinea-pig. This effect of cisplatin is mediated by a cascade of events which involves release of acetylcholine and stimulation of 5-HT3 receptors.
Similar content being viewed by others
References
Andrews PLR, Hawthorn J (1988) The neurophysiology of vomiting. Balliere's Clinical Gastroenterology 2:1367–1370
Andrews PLR, Rapeport WG, Sanger GJ (1988) Neuropharmacology of emesis induced by anti-cancer therapy. Trends Pharmacol Sci 9:334–341
Barnes NM, Costall B, Naylor RJ, Tattersall FD (1988) Identification of 5-HT3 recognition sites in the ferret area postrema. J Pharm Pharmacol 40:586–588
Barnes NM, Ge J, Jones WG, Naylor RJ, Rudd JA (1990) Cisplatin induced emesis: preliminary results indicative of changes in plasma levels of 5-hydroxytryptamine. Br J Cancer 62:862–864
Buchheit KH, Engel G, Mutschler E, Richardson B (1985) Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileum. Evidence for two distinct release mechanisms. Naunyn-Schmiedeberg's Arch Pharmacol 329:36–41
Butler A, Elswood CJ, Burridge J, Ireland SJ, Bunce KT, Kilpatrick GJ, Tyres MB (1990) The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues. Br J Pharmacol 101:591–598
Cubeddu LX, Hoffmann IS, Fuenmayor NT, Finn AL (1990) Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 322:810–816
Dolley DJ, Bittiger H, Reymann NC (1986) CGP 20712: a useful tool for quantitating β1- and β2-adrenoceptors. Eur J Pharmacol 130:137–139
Fozard JR (1989) Development and early clinical evaluation of selective 5-HT3 receptor antagonists. In: Fozard JR (ed) Peripheral actions of 5-hydroxytryptamine. Oxford University Press, Oxford, pp 354–376
Gunning SJ, Hagan RM, Tyres MB (1987) Cisplatin induces biochemical and histological changes in the small intestine of the ferret. Br J Pharmacol 90:135P
Hawthorn J, Ostler KJ, Andrews PLR (1988) The role of abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cisplatin in the ferret. Q J Exp Physiol 73:7–21
Higgins GA, Kilpatrick GJ, Bunce KT, Jones RJ, Tyers MB (1989) 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br J Pharmacol 97:247–255
Holzer P, Lembeck F (1979) Effect of neuropeptides on the efficiency of the peristaltic reflex. Naunyn-Schmiedeberg's Arch Pharmacol 307:257–264
Hoyer D (1990) 5-HT3, 5-HT4 and 5-HT-M receptors. Neuropsychopharmacology 3:371–383
Kilbinger H, Pfeuffer-Friederich I (1985) Two types of receptors for 5-hydroxytryptamine on the cholinergic nerves of the guinea-pig myenteric plexus. Br J Pharmacol 85:529–539
Kilbinger H, Wessler I (1980) Inhibition by acetylcholine of stimulation-evoked release of 3H-acetylcholine from the guinea-pig myenteric plexus. Neuroscience 5:1331–1340
Kilpatrick GJ, Jones BJ, Tyers MB (1989) Binding of the 5-HT3 ligand, [3H]GR 65630, to rat area postrema, vagus nerve and the brains of several species. Eur J Pharmacol 159:157–164
Marin J, Ibañez MC, Arribas S (1990) Therapeutic management of nausea and vomiting. Gen Pharmacol 21:1–10
Marty M, Pouillar P, Scholl S, Droz JP, Azab M, Brion N, Pujade-Lauraine E, Paule B, Paes D, Bons J (1990) Comparison of the 5-hydroxytryptamine (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Eng J Med 322:316–321
Muscholl E, Racké H, Traut A (1985) Gadolinium ions inhibit exocytotic vasopressin release from rat neurohypophysis. J Physiol 367:419–434
Racké K, Schwörer H, Kilbinger H (1988) Adrenergic modulation of the release of 5-hydroxytryptamine from the vascularly perfused ileum of the guinea-pig. Br J Pharmacol 95:923–931
Racké K, Schwörer H, Kilbinger H (1990) Effects of the benzodiazepine receptor agonist midazolam and antagonist flumazenil on 5-hydroxytryptamine release from guinea-pig intestine in vitro. Indirect support for a “natural” benzodiazepine-like substance in the intestine. Naunyn-Schmiedeberg's Arch Pharmacol 341:1–7
Richardson BP, Engel G (1986) The pharmacology and function of 5-HT3 receptors. Trend Neurosci 9:424–428
Schwörer H, Racké K (1989) Effects of cisplatin on the release of 5-hydroxytryptamine from guinea-pig small intestine. Involvement of 5-HT3 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 339:R96
Schwörer H, Racké K, Kilbinger H (1987a) Spontaneous release of endogenous 5-hydroxytryptamine and 5-hydroxyindoleacetic acid from the isolated vascularly perfused ileum of the guinea-pig. Neuroscience 21:297–303
Schwörer H, Racké K, Kilbinger H (1987b) Cholinergic modulation of the release of 5-hydroxytryptamine from the guinea pig ileum. Naunyn-Schmiedeberg's Arch Pharmacol 336:127–132
Schwörer H, Racké K, Kilbinger H (1989a) GABA-ergic modulation of the release of 5-hydroxytryptamine from the vascularly perfused small intestine of the guinea-pig. Eur J Pharmacol 165:29–37
Schwörer H, Racké K, Kilbinger H (1989b) Characterization of the muscarine receptors involved in the modulation of serotonin release from the vascularly perfused small intestine of guinea pig. Naunyn-Schmiedeberg's Arch Pharmacol 339:263–267
Smith DB, Newlands ES, Rustin GJ, Begent RH, Crawford SM, Bagshawe KD, Carruthers L (1990) A phase I/II study of the 5-HT3 antagonist GR 38032F in the anti-emetic prophylaxis of patients receiving high-dose cisplatin chemotherapy. Cancer Chemother Pharmacol 25:291–294
Stewart DJ (1990) Cancer therapy, vomiting, and antiemetics. Can J Physiol Pharmacol 68:304–313
Wallenstein S, Zucker CL, Fleiss JL (1980) Some statistical methods useful in circulation research. Circ Res 47:1–9
Wellhöner HH (1988) Allgemeine and systematische Pharmakologie und Toxikologie. Springer, Berlin Heidelberg New York London Paris Tokyo, pp 422–423
Author information
Authors and Affiliations
Additional information
Send offprint requests to H. Schwörer at his present address
Rights and permissions
About this article
Cite this article
Schwörer, H., Racké, K. & Kilbinger, H. Cisplatin increases the release of 5-hydroxytryptamine (5-HT) from the isolated vascularly perfused small intestine of the guinea-pig: Involvement of 5-HT3 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 344, 143–149 (1991). https://doi.org/10.1007/BF00167211
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00167211